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FIBROBLAST migration,  proliferation,  extracellular
matrix protein synthesis and degradation, all of which
play important roles in inflammation, are themselves
induced by various growth factors and cytokines. Less
is known about the interaction of these substances on
lung fibroblast function in pulmonary fibrosis.
The goal of this study was to investigate the effects
of  PDGF alone and in combination with IL–1b and
TNF-a on the  production of  human  lung fibroblast
matrix  metalloproteinases,  proliferation,  and  the
chemotactic  response.  The  assay  for  MMPs  activity
against FITC labeled type I and IV collagen was based
on the specificity of the enzyme cleavage of collagen.
Caseinolytis  and  gelatinolytic  activities  of  secreted
proteinases  were  analyzed  by  zymography.  Fibro-
nectin  in  conditioned  media  was  measured  using
human lung fibronectin enzyme immunoassay. Cell
proliferation was measured by 3H-Thymidine incor-
poration assay. Cell culture supernatants were tested
for PGE2 content by ELISA. Chemotactic activity was
measured using the modified Boyden chamber.
Matrix metalloproteinase assay  indicated  that IL–
1b ,  TNF-a and PDGF induced intestitial collagenase
(MMP–1) production. MMP assay also indicated that
IL–1b and  TNF-a had  inhibitory  effects  on  MMP-
2,9(gelatinaseA,B)  production.  Casein  zymography
confirmed that IL–1b stimulated stromlysin (matrix
metalloproteinase  3;  MMP–3)  and  gelatin  zymog-
raphy demonstrated that TNF-a induced MMP–9 pro-
duction  in  human  lung  fibroblast,  whereas  PDGF
alone did not. PDGF in combination with IL–1b and
TNF-a induced MMP–3 and MMP-9 activity, as demon-
strated by zymography. PDGF stimulated lung fibro-
blast  proliferation  in  a  concentration-dependent
manner,  whereas  IL–1b and  TNF-a alone  had  no
effect.  In contrast,  the proliferation of  human lung
fibroblasts by PDGF was inhibited in the presence of
IL–1b and  TNF-a ,  and  this  inhibition  was  not  a
consequence of any elevation of PGE2. PDGF stimu-
lated  fibroblast  chemotaxis  in  a  concentration-
dependent  manner,  and  this  stimulation  was  aug-
mented by combining PDGF with IL–1b and TNF-a .
These  findings suggested  that  PDGF differentially
regulated  MMPs  production  in  combination  with
cytokines,  and  further  that  MMP  assay  and  zymog-
raphy had differential sensitivity for detecting MMPs.
The  presence  of  cytokines  with  PDGF  appears  to
modulate the proliferation and chemotaxis of human
lung fibroblasts.
Key words: Metalloproteinase, PDGF, IL–1b, TNF-a, Lung
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Introduction
Pulmonary fibrosis and other fibrotic lung diseases are
characterized by diffuse intestitial inflammation and
exaggerated  collagen  accumulation.  This  in  turn
leads  to  destruction  of  alveolar  structures  and
remodeling.1
Fibroblast  migration,  proliferation,  extracellular
matrix  protein  synthesis  and  degradation,  all  of
which  play  important  roles  in  inflammation,  are
themselves  induced  by  various  cytokines,  such  as
IL–1b and TNF-a, and growth factors, such as TGF
and PDGF, as well as by the combined use of these
agents.2–8 Less  is  known  about  the  interaction  of
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pulmonary fibrosis.
Recent studies have shown that some extracellular
matrix  components, including  collagen,  fibronectin
and cytokines (e.g. PDGF and TGF) have an effect on
fibroblast chemotactic responses.3,8 The role of PDGF
in combination with cytokines in fibroblast collagen
production  or  degradation  is  unclear.  By  using  a
Boyden chamber to assay chemotaxis, the migration
of fibroblasts across collagen-coated filters was shown
to be a response to proteinase products of fibroblasts
as  well  as  to  the  products  of  malignant  cells.9,10
Stromelysin  (matrix  metalloproteinase–3,  MMP–3)
and the type IV procollagenase (matrix metalloprotei-
nase–9, gelatinase B) are known to degrade a wide
range  of  extracellular  matrix  molecules,  including
proteoglycan,  gelatin,  type  IV  and V  collagen,  and
fibronectin.
Recent evidence suggests that matrix metallopro-
teinases  (MMPs),  including  MMP-2(gelatinase  A),
MMP–3 and MMP–9 play major roles in the degrada-
tion of the extracellular matrix in tumor invasion.10–13
Interestingly, cytokines when applied in combination
can stimulate the release of these proteinases from
fibroblasts, which degrade to a number of structural
proteins  of  the  extracellular  matrix,  in  addition  to
intestitial collagen.14,15
The present study investigated the effect of PDGF
alone and in combination with IL-1b and TNF-a on
MMPs production, proliferation and the chemotactic
response of human lung fibroblast in vitro.
Materials and methods
Materials
Recombinant human  PDGF-BB  was purchased from
Genzyme  (MA,  USA).  IL–1b was  purchased  from
Otsuka  Pharmaceutical  Co  (Tokushima,  Japan)  and
TNF-a were  from  Hayashibara  Biochemical  Labo-
ratories Inc (Okayama, Japan).
Cell culture
Human lung fibroblasts CCL–153 obtained from the
American Type Culture Collection (ATCC) were cul-
tured in a cell culture flask, in modified Ham’s F12
(SIGMA) medium supplemented with 10% fetal calf
serum at 37°C in an atmosphere of 5% CO2 and 95%
air and plated at a density of 1.0 ´ 105 cell in a 24-well
plate until confluence.
Metalloproteinases (MMP) assay
The assay for MMPs activity against FITC labeled type
I and IV collagen was based on the specificity of the
enzyme cleavage of collagen. One unit of collagenase
activity  was  defined  as  the  amount  of  enzyme
degrading 1mg of collagen per minute at 37°C. The
specificity of the assay was confirmed by identifica-
tion  of  collagenase  reaction  products  by  immuno-
fluoresence  electrophotometry,  as  described
previously.16
Zymographic analysis of metalloproteinases
Caseinolytis  and  gelatinolytic  activities  of  secreted
proteinases were analyzed by zymography according
to the methods of Chin et al.14 with some modifica-
tions.  SDS-polyacrylamid  gels  contain  1.25mg/ml
casein or 1mg/ml gelatin. Samples to be tested were
mixed with an equal volume of the concentrated SDS
sample buffer and then electrophoresed on casein or
gelatin-containing  gels. After  electrophoresis  of  the
gels,  the  separated  proteinases  were  renatured  by
gentle  shaking  of  the  gel  in  2.5%  Triton  X–100
containing 50 mM Tris-HCl and 0.1m NaCl at room
temperature  for  1h  to  remove  SDS,  followed  by
incubation  in  250ml  of  50 mM Tris-HCl  containing
10 mM  CaCl2 and  0.02  NaN3 at  37°C  for  approx-
imately  18h. The  resultant  gels  were  stained  with
Coomassie brilliant blue.
Fibronectin assay
Fibroblasts were incubated in serum-free F12 medium
or with growth factor and cytokines for 24h. Fibro-
nectin  in  conditioned  media  was  measured  using
human lung fibronectin enzyme immunoassay accord-
ing  to  the  manufacturer’s  instructions,  purchased
from Paesel (Frankfurt, Germany).
3H-Thymidine incorporation assay
Cells were incubated in serum-free F12 medium, or
with growth factor and cytokines for 24h and then
pulsed with  3H-Thymidine (0.04mCi/ml). Incorpora-
tion  of  3H-Thymidine  was  measured  24h  later  by
detaching cells with trypsin solution and harvesting
the cells on filters using a cell harvester. Radioactivity
on  the  filters  was  determined  using  scintillation
counting.
Prostaglandin E2 assay
Cell  culture  supernatants  were  tested  for  PGE2
content by ELISA kits according to the manufacturer’s
instructions (purchased from Neogec Corporation).
Chemotaxis assay
Chemotactic activity  was measured using  the mod-
ified Boyden chamber as described previously.9 The
chemotactic agent was diluted in Ham’s F12 medium
and placed in the lower well chamber. The lower well
was then covered with a collagen-coated polycarbo-
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added to the upper well of the chamber containing
Ham’s F12 medium. After 8h incubation at 37°C in
95% air and 5% CO2, the filters were removed and
cells were fixed and stained using Diff-Quik stain. The
chemotactic respose was analyzed by  counting  the
number  of  cells/microscopic  field  on  the  lower
surface of the filter. The stimulation  index (SI) was
expressed as follows: SI = number of migrating cells
with  PDGF  or  cytokines/number  of  migrating  cells
without PDGF.
Data analysis
A comparison of proliferation and chemotaxis within
experiments  was  performed  using  Student’s  t-test.
Statistical significance was accepted at p < 0.05.
Results
Matrix metalloproteinase production
IL–1b,  TNF-a and  PDGF  caused  a  significant
increase in matrix metalloproteinase activity (MMP–
1;  Fig.  1).  In  contrast,  MMP–2,9  activity  was  sig-
nificantly reduced by IL–1b, TNF-a and PDGF (Fig.
1). TNF-a alone and PDGF in combination with IL–
1b and  TNF-a stimulated  MMP–9  production  in
lung  fibroblasts,  whereas  neither  PDGF  alone  nor
IL-1b alone did so (Fig. 2a). Various combinations of
PDGF  with  IL–1b or TNF-a also  induced  MMP–3
activity (Fig. 2b).
Fibronectin production
IL–1b and TNF-a,  either  alone  or  in  combination,
both  failed  to  significantly  alter  basal  fibronectin
production  in  human  fibroblasts  in  culture  in  the
absence of PDGF (Fig. 3, p > 0.05). In contrast, PDGF
alone (10ng/ml)  significantly  stimulated fibronectin
production (control 2.2±0.4mg/ml vs PDGF 10ng/ml
4.3±0.7mg/ml, p < 0.05; Fig. 3). However, both IL–1b
and  TNF-a,  as  well  as  the  combination  of  these
cytokines,  significantly  inhibited  the  increase  in
fibronectin  production  induced  by  PDGF  (10ng/
ml)(p < 0.05; Fig. 3).
Fibroblast proliferation
PDGF  stimulated  proliferation  as  assessed  by
3H-Thymidine  incorporation  in  fibroblasts  (control
2050±298 dpm, PDGF 1ng/ml 3490±350 dpm, PDGF
10ng/ml 8728±294 dpm, p < 0.05). Either IL–1b or
TNF-a alone failed to significantly alter basal prolifera-
tion in human fibroblasts cultured with PDGF (data
not shown). The proliferation of  human  lung  fibro-
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FIG.  1.  Matrix  metalloproteinases  activity  in  human  lung
fibroblasts stimulated for 24h with IL–1b (10ng/ml), TNF-a
(10ng/ml) and PDGF (5ng/ml). Bar graph representing the
activity  of  MMP–1,  light-shaded  column  and  MMP–2,9,
oblique-lined column.
FIG. 2. Zymographic analysis of metalloproteinase expres-
sion by fibroblasts treated with PDGF, IL–1b and TNF-a. (a)
Supernatants  from  untreated fibroblasts  (lane  1) or  fibro-
blasts treated (lanes 2–8) for 24 h with PDGF (5ng/ml), IL–
1b (10ng/ml), or TNF-a (10ng/ml) or in combination were
analyzed  by  gelatin  zymography for  detection  of  MMP–2
and  MMP–9.  (b)  Supernatants  from  untreated  fibroblasts
(lane 1) or fibroblasts treated (lanes 2–8) for 24h with PDGF
(5ng/ml), IL–1b (10ng/ml), or TNF-a (10ng/ml) or in combi-
nation were analyzed by casein  zymography for  detection
of MMP–3.blasts  by  PDGF  was  significantly  inhibited  in  the
presence of IL–1b and TNF-a in combination but this
effect only achieved statistical significance with PDGF
(10ng/ml; p < 0.05, Fig. 4).
Prostaglandin E2 assay
Under  basal  conditions,  human  lung  fibroblasts  in
culture produced very little PGE2 (<0.5ng/ml). Incu-
bation of human lung fibroblasts with IL–1b (10ng/
ml) or TNF-a (10ng/ml) alone or in combination for
24h did not significantly  increase PGE2 production
(Table 1). Incubation of human lung fibroblasts with
IL–1b (10ng/ml) or IL-1b (10ng/ml) in combination
with  TNF-a (10ng/ml)  for  72h  increased  PGE2
production,  which  inhibited  fibroblast  proliferation
(Table  1).  PDGF  did  not  augment  the  PGE2 pro-
duction  induced  by  IL–1b (10ng/ml)  or  TNF-a
(10ng/ml) alone or in combination for 24h.
Fibroblast chemotaxis
Neither IL–1b, TNF-a nor the combination of these
two  cytokines  significantly  stimulated  fibroblast
chemotaxis  in  the  absence  of  PDGF  (Fig.  5).  In
contrast,  PDGF  (10ng/ml)  significantly  increased
fibroblast chemotaxis (control 3.8±0.5 cells vs PDGF
8.5±0.5 cells, p < 0.05, SI = 2.3±0.2), whereas IL–1b
(p <  0.05  cf.  control)  and  TNF-a (p <  0.05  cf.
control)  significantly  inhibited  chemotaxis  induced
by PDGF (10ng/ml). However, no significant inhibi-
tion was observed when both cytokines were pres-
ent (Fig. 5).
Discussion
In pulmonary fibrosis, the fibrotic process is thought
to be  initiated by a variety of events following cell
migration including extracellular matrix degradation,
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FIG.  3.  Fibronectin  production  in  human  lung  fibroblasts
stimulated for 24h with PDGF (5ng/ml), IL–1b (10ng/ml), or
TNF-a (10ng/ml).  Bar  graph  representing  tha  fibronectin
production stimulated by IL–1b, light-shaded column, TNF-a,
oblique-lined  column  and  in  combination,  dark-shaded
column.
FIG. 4. Effects of PDGF, IL–1b and TNF-a in combination on
3H-Thymidine incorporation by fibroblasts. The average cpm
incorporated by untreated fibroblasts was defined as  100.
Values  give  incorporation  of  specified  radiolabeled  sub-
stances  as  percentage incorporation. Bars  indicate means
with SEM derived from one of three experiments with six
replicates for each mean. p < 0.05 compared with untreated
fibroblasts.
Table  1.  The  effect  of  IL–1b and  TNF-a either  alone or  in  combination  on  fibroblast  PGE2
production. PGE2 was measured by ELISA as described in Materials and Methods
Cytokines Level of PGE2 (ng/ml)
24h 72h
IL-1b (10ng/ml) < 0.5 3.65+3.0
TNF-a (10ng/ml) < 0.5 0.84+0.6
IL-1b + TNF-a < 0.5 8.06+4.5
IL-1b (10ng/ml) +PDGF(5ng/ml) < 0.5
TNF-a (10ng/ml) + PDGF(5ng/ml) < 0.5
IL-1b + TNF-a +PDGF < 0.5cell proliferation and remodeling. These phenomena
are  induced  by  growth  factors  and  cytokines  pro-
duced  by  infiltrating  platelets,  macrophages,  fibro-
blasts and residential cells. Of particular interest is the
role  of  PDGF  in  this  process  given  the  recently
reported finding that PDGF-like proteins are localized
in macrophages and epithelial cells of patients with
idiopathic  pulmonary  fibrosis.17–21 Lung  fibroblasts
are also reported to be capable of synthesizing growth
factors known to stimulate fibroblast proliferation in
vivo, which in turn suggests an autocrine pathway for
proliferation of these cells.21–24
Cytokines such as TNF-a have also been reported to
stimulate  PDGF  secretion-dependent fibroblast  pro-
liferation.25,26 Several  experiments  have  demon-
strated that lung fibroblasts have different potentials
to  produce collagenase during  the development of
pulmonary  fibrosis.27–29 However,  little  is  known
concerning the interaction between PDGF, IL-1b and
TNF-a during  pulmonary  inflammation.  We  have
demonstrated that PDGF in combination with IL–1b
and TNF-a stimulated the lung fibroblast production
of MMP–3 and MMP–9. Under similar conditions, the
proliferation, but not the migration, of lung fibroblasts
was inhibited.
Bronchoalveolar  lavage  fluid  from  patients  with
idiopathic  fibrosis  contain  a  high  level  of  active
collagenase.30 Matrix  metalloproteinases,  such  as
MMP–1,  MMP–3  and  MMP–9,  are  important  in
catalyzing  the  destruction  of  collagen,  fibronectin,
gelatin  and  other  extracellular  matrix  proteins  in
inflammation. Tumor cells in culture with metastatic
potential  have  been  demonstrated  to  secrete
MMPs.14,15 Cytokines  including  TGF-a and  IL–1b
augmented the synthesis of MMP–9 in murine skin
fibroblasts.31 Our experiments suggested that MMP–1
and  MMP–2  were  spontaneously  released, whereas
MMP–3  and  MMP–9  were  not  from  human  lung
fibroblasts. In addition, MMP–3 and MMP–9 were also
not  induced  by  PDGF  alone.  In  contrast,  IL–1b
stimulates MMP–3 production while TNF-a stimulates
MMP–9  production. Furthermore, we provided evi-
dence for the coordination of the effects of IL–1b and
TNF-a in reducing MMP–3 and MMP–9 production.
However, the major finding of the present study was
the  synergistic  production  of  MMP–3  and  MMP–9
induced by PDGF combined with IL–1b, TNF-a and
both cytokines. This finding suggested that PDGF has
a complex impact on MMP production in human lung
fibroblasts, with the mechanism underlying this effect
remaining  to  be  established. A possible mechanism
may  involve  PDGF  acting  on  the  transcription
pathway.
IL–1b and TNF-a have been reported to enhance
and  inhibit  respective  collagen  production  in  lung
fibroblasts.28 We have shown that IL–1b and TNF-a
had no effect of fibronectin production. PDGF had an
effect  on  fibronectin  production,  which  was  not
augmented by IL–1b and TNF-a. Under these condi-
tions, PDGF may play the main role in human lung
proliferation and contribute to cell migration in the
early stages of inflammation. PDGF is released from
a-granules found in platelets and is not only a mitogen
for connective tissue cells in vitro, but is also a potent
chemotactic agent for fibroblasts and smooth muscle
cells.32–34 IL–1b alone  and  TNF-a alone  had  no
synergistic  effect  on  PDGF-induced  fibroblast  pro-
liferation in this experiment (data not shown). In the
presence  of  IL–1b and  TNF-a,  the  proliferation
induced  by  PDGF  was  inhibited,  while  the  chem-
otactic response to PDGF was increased.
It  is  known  that IL–1b stimulates  the  release of
PGE2,  which  in  turn  inhibits  fibroblast  prolifera-
tion.35,36 Our experiment suggested that under our
experimental conditions, PGE2 does not play a role
in  fibroblast  proliferation.  Indomethacine  did  not
reverse the inhibitory effects of IL–1band TNF-a on
fibroblast  proliferation  (data  not  shown).  These
results  suggest  that  the  inhibition  caused  by  the
combination of these cytokines is unrelated to fiblo-
blast  prostaglandine  synthesis.  Transmodulation  of
the PDGF receptor by IL–1b or the transmodulation
of the FGF receptor by PDGF have been shown to
occur  in  other  systems.37,38 The  possibility  exists
that  PDGF  modulates  IL–1b and  TNF-a receptor
expression.
The present results indicated that PDGF in combi-
nation with IL–1b and TNF-a differentially regulated
metalloproteinase  production,  proliferation  activity
and the chemotactic response in lung fibroblasts.
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FIG. 5. Fibroblast chemotaxis treated with PDGF, IL–1b, or
TNF-a for 8h. Responses are expressed as SI. The SI was
calculated as described in Materials and Methods. Each bar
is the average of triplicate values. Four experiments were
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